Hongqin Xu

1.4k total citations
46 papers, 885 citations indexed

About

Hongqin Xu is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Hongqin Xu has authored 46 papers receiving a total of 885 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Epidemiology, 30 papers in Hepatology and 9 papers in Molecular Biology. Recurrent topics in Hongqin Xu's work include Liver Disease Diagnosis and Treatment (33 papers), Hepatitis C virus research (16 papers) and Hepatitis B Virus Studies (15 papers). Hongqin Xu is often cited by papers focused on Liver Disease Diagnosis and Treatment (33 papers), Hepatitis C virus research (16 papers) and Hepatitis B Virus Studies (15 papers). Hongqin Xu collaborates with scholars based in China, United States and India. Hongqin Xu's co-authors include Ruihong Wu, Junqi Niu, Yanhang Gao, Pujun Gao, Junqi Niu, Xiaomei Wang, Xiuzhu Gao, Xu Li, Wenjun Wang and Chunguang Wang and has published in prestigious journals such as Scientific Reports, The FASEB Journal and Journal of Hepatology.

In The Last Decade

Hongqin Xu

45 papers receiving 873 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hongqin Xu China 18 510 338 194 166 120 46 885
Chih‐Lang Lin Taiwan 17 498 1.0× 432 1.3× 111 0.6× 82 0.5× 68 0.6× 87 921
Marco Biolato Italy 18 455 0.9× 420 1.2× 135 0.7× 135 0.8× 58 0.5× 50 965
Yong Jin Jung South Korea 21 590 1.2× 475 1.4× 219 1.1× 75 0.5× 113 0.9× 76 1.1k
Feng Shen China 18 594 1.2× 538 1.6× 177 0.9× 131 0.8× 140 1.2× 46 1.1k
Jaswinder Singh Maras India 15 366 0.7× 248 0.7× 239 1.2× 112 0.7× 57 0.5× 61 749
Mie Inao Japan 16 381 0.7× 486 1.4× 204 1.1× 93 0.6× 66 0.6× 48 913
Mi Na Kim South Korea 21 884 1.7× 756 2.2× 126 0.6× 72 0.4× 89 0.7× 75 1.2k
Fernando Magdaleno Spain 14 363 0.7× 256 0.8× 161 0.8× 94 0.6× 54 0.5× 30 763
Melisa Dirchwolf Argentina 14 512 1.0× 543 1.6× 221 1.1× 51 0.3× 169 1.4× 27 987
Seiichi Mawatari Japan 16 383 0.8× 233 0.7× 145 0.7× 84 0.5× 57 0.5× 49 731

Countries citing papers authored by Hongqin Xu

Since Specialization
Citations

This map shows the geographic impact of Hongqin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongqin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongqin Xu more than expected).

Fields of papers citing papers by Hongqin Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongqin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongqin Xu. The network helps show where Hongqin Xu may publish in the future.

Co-authorship network of co-authors of Hongqin Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Hongqin Xu. A scholar is included among the top collaborators of Hongqin Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongqin Xu. Hongqin Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Shengnan, Hao Zhu, Lin Pan, et al.. (2023). Systemic inflammatory regulators and risk of acute-on-chronic liver failure: A bidirectional mendelian-randomization study. Frontiers in Cell and Developmental Biology. 11. 1125233–1125233. 51 indexed citations
3.
Liu, Yuwei, et al.. (2022). No evidence for a causal link between Helicobacter pylori infection and nonalcoholic fatty liver disease: A bidirectional Mendelian randomization study. Frontiers in Microbiology. 13. 1018322–1018322. 22 indexed citations
4.
Xu, Hongqin, et al.. (2022). Epidemic characteristics of alcohol‐related liver disease in Asia from 2000 to 2020: A systematic review and meta‐analysis. Liver International. 42(9). 1991–1998. 20 indexed citations
5.
Xu, Hongqin, Chunguang Wang, Qiang Zhou, & Yanhang Gao. (2021). Effects of alcohol consumption on viral hepatitis B and C. World Journal of Clinical Cases. 9(33). 10052–10063. 26 indexed citations
6.
Zhang, Mingyuan, et al.. (2020). Neutrophil‐to‐Lymphocyte Ratio and Albumin: New Serum Biomarkers to Predict the Prognosis of Male Alcoholic Cirrhosis Patients. BioMed Research International. 2020(1). 7268459–7268459. 11 indexed citations
7.
Wu, Ruihong, Xu Liu, Hongqin Xu, et al.. (2020). <p>Validation of the GALAD Model and Establishment of GAAP Model for Diagnosis of Hepatocellular Carcinoma in Chinese Patients</p>. Journal of Hepatocellular Carcinoma. Volume 7. 219–232. 32 indexed citations
8.
Xu, Hongqin, et al.. (2020). Efficacy and Safety of Glecaprevir/Pibrentasvir for Chronic Hepatitis C Patients: A Systematic Review and Meta-analysis. Journal of Clinical and Translational Hepatology. 8(4). 1–10. 2 indexed citations
9.
Wang, Wenjun, et al.. (2019). Growing burden of alcoholic liver disease in China: A review. World Journal of Gastroenterology. 25(12). 1445–1456. 71 indexed citations
10.
Xu, Hongqin, et al.. (2019). Fibrosis Index Based on 4 Factors (FIB-4) Predicts Liver Cirrhosis and Hepatocellular Carcinoma in Chronic Hepatitis C Virus (HCV) Patients. Medical Science Monitor. 25. 7243–7250. 20 indexed citations
11.
Zhang, Yanan, et al.. (2019). Hepatocellular carcinoma in the noncirrhotic liver: a literature review. European Journal of Gastroenterology & Hepatology. 31(7). 743–748. 13 indexed citations
12.
Seo, Wonhyo, Yanhang Gao, Yong He, et al.. (2019). ALDH2 deficiency promotes alcohol-associated liver cancer by activating oncogenic pathways via oxidized DNA-enriched extracellular vesicles. Journal of Hepatology. 71(5). 1000–1011. 150 indexed citations
13.
Zhang, Yingyu, Hongqin Xu, Xiumei Chi, et al.. (2018). High level of serum Cripto-1 in hepatocellular carcinoma, especially with hepatitis B virus infection. Medicine. 97(35). e11781–e11781. 10 indexed citations
14.
Wu, Jing, Hongqin Xu, Xiumei Chi, et al.. (2018). Non-alcoholic fatty liver disease incidence, remission and risk factors among a general Chinese population with a 6-year follow-up. Scientific Reports. 8(1). 7557–7557. 13 indexed citations
15.
Wang, Zhongfeng, Xu Liu, Hongqin Xu, et al.. (2018). Platelet count to spleen thickness ratio is related to histologic severity of primary biliary cholangitis. Medicine. 97(7). e9843–e9843. 7 indexed citations
16.
Li, Xu, Yang Gao, Hongqin Xu, Jie Hou, & Pujun Gao. (2017). Diabetes mellitus is a significant risk factor for the development of liver cirrhosis in chronic hepatitis C patients. Scientific Reports. 7(1). 9087–9087. 19 indexed citations
17.
Chi, Xiumei, Ruihong Wu, Hongqin Xu, et al.. (2016). Sustained viral response and treatment‐induced cytopenia correlate with SLC s and KLF12 genotypes in interferon/ribavirin‐treated Chinese chronic hepatitis C patients. Journal of Gastroenterology and Hepatology. 31(8). 1489–1497. 3 indexed citations
18.
Wang, Huan, Hongqin Xu, Limei Qu, et al.. (2016). Red blood cell distribution width and globulin, noninvasive indicators of fibrosis and inflammation in chronic hepatitis patients. European Journal of Gastroenterology & Hepatology. 28(9). 997–1002. 37 indexed citations
19.
Wang, Huan, Hongqin Xu, Xiaomei Wang, et al.. (2016). Red Blood Cell Distribution Width to Platelet Ratio is Related to Histologic Severity of Primary Biliary Cirrhosis. Medicine. 95(11). e3114–e3114. 36 indexed citations
20.
Xu, Hongqin, Juan Lv, Moli Wang, et al.. (2015). Use of parenteral caffeinum natrio-benzoicum: an underestimated risk factor for HCV transmission in China. BMC Public Health. 15(1). 928–928. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chih‐Lang Lin Breakdown of academic impact, for papers by Marco Biolato Breakdown of academic impact, for papers by Yong Jin Jung Breakdown of academic impact, for papers by Feng Shen Breakdown of academic impact, for papers by Jaswinder Singh Maras Breakdown of academic impact, for papers by Mie Inao Breakdown of academic impact, for papers by Mi Na Kim Breakdown of academic impact, for papers by Fernando Magdaleno Breakdown of academic impact, for papers by Melisa Dirchwolf Breakdown of academic impact, for papers by Seiichi Mawatari
Rankless by CCL
2026